local coverage determination Palmetto Finalizes Medicare Coverage for MRD Cancer Testing To receive coverage, the patient must have a personal history of cancer where the type and staging are within the intended use of the test. Veracyte Bladder Cancer Test Receives Medicare Coverage The patient must be a candidate for multiple potential treatments with varying levels of intensity or multiple therapies. Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Under the policy, covered tests must provide information about active rejection status or cellular or antibody-mediated rejection status. Local Coverage Determinations Roundup: Castle Bio A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors. CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests The company's AlloSure Kidney test received coverage, along with its AlloSure Heart test when used with the firm's AlloMap test. Nov 13, 2020 Clinical Genomics Nabs Medicare Coverage for Colorectal Cancer Test as Novitas Revises LCD Nov 6, 2020 Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Oct 28, 2020 Strata Oncology Receives Medicare Coverage for NGS Test Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 12, 2020 Pacific Edge Diagnostics Receives Medicare Coverage for Bladder Cancer Test Oct 8, 2020 Castle Bio Receives Expanded Medicare Coverage for Melanoma Test Oct 5, 2020 Resolution Bio Seeks to Widen Private Payor Coverage Following Lung Cancer Liquid Biopsy Launch Premium Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Sep 25, 2020 Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test Sep 25, 2020 Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD Sep 10, 2020 Two Medicare Contractors Align Coverage for MRD Testing With Palmetto Sep 3, 2020 Natera Receives LCD From Palmetto for Signatera MRD Test in Colorectal Cancer Patients Jul 31, 2020 Medicare to Cover Myriad Genetics' BRACAnalysis for FDA-Approved CDx Indications Jul 15, 2020 Noridian Providing Limited Coverage for MDx Tests as Predictive Classifiers for NSCLC Jul 2, 2020 Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020 Jul 2, 2020 Noridian Aligns With Palmetto on Single-Gene, Multi-Gene PGx Test Coverage Jul 1, 2020 Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index Jun 19, 2020 Local Coverage Determinations Roundup: Razor Genomics, Guardant Health Jun 11, 2020 Palmetto Providing Limited Coverage for Single-Gene, Multi-Gene PGx Tests Load More Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.